WO2024084287 - COMPOSITION FOR NEAR INFRARED LYMPHATIC IMAGING AND USES AND DOSAGES THEREFOR
National phase entry:
Publication Number
WO/2024/084287
Publication Date
25.04.2024
International Application No.
PCT/IB2023/000642
International Filing Date
20.10.2023
Title **
[English]
COMPOSITION FOR NEAR INFRARED LYMPHATIC IMAGING AND USES AND DOSAGES THEREFOR
[French]
COMPOSITION POUR IMAGERIE LYMPHATIQUE PROCHE INFRAROUGE ET UTILISATIONS ET DOSAGES ASSOCIÉS
Applicants **
ASTELLAS PHARMA INC.
Inventors
KIMURA, Sadaaki
FUSHIKI, Hiroshi
DELGADO-HERRERA, Leticia
RAIZER, Jeffrey
Priority Data
63/418,298
21.10.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2890 | |
| EPO | Filing, Examination, Granting | 23504 | |
| Japan | Filing, Examination, Granting | 3118 | |
| South Korea | Filing, Examination, Granting | 3883 | |
| USA | Filing, Examination, Granting | 11540 |
Total:
44,935
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed are imaging agents for near-infrared imaging of lymph nodes or lymphatic vessels that can be used to selectively image the primary lymph node relative to secondary and subsequent lymph nodes and dosages for this composition suitable for imaging lymph nodes or lymphatic vessels.[French]
L'invention concerne des agents d'imagerie pour l'imagerie proche infrarouge de ganglions lymphatiques ou de vaisseaux lymphatiques qui peuvent être utilisés pour imager sélectivement le ganglion lymphatique primaire par rapport à des ganglions lymphatiques secondaires et ultérieurs et des dosages pour cette composition appropriés pour l'imagerie de ganglions lymphatiques ou de vaisseaux lymphatiques.